Hanie Yousefi


Curriculum vitae


Postdoctoral Fellow

Chan Zuckerberg Biohub



Strategies for Biomolecular Analysis and Continuous Physiological Monitoring.


Journal article


A. Clifford, Jagotamoy Das, Hanie Yousefi, Alam Mahmud, Jenise B. Chen, S. Kelley
Journal of the American Chemical Society, 2021

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Clifford, A., Das, J., Yousefi, H., Mahmud, A., Chen, J. B., & Kelley, S. (2021). Strategies for Biomolecular Analysis and Continuous Physiological Monitoring. Journal of the American Chemical Society.


Chicago/Turabian   Click to copy
Clifford, A., Jagotamoy Das, Hanie Yousefi, Alam Mahmud, Jenise B. Chen, and S. Kelley. “Strategies for Biomolecular Analysis and Continuous Physiological Monitoring.” Journal of the American Chemical Society (2021).


MLA   Click to copy
Clifford, A., et al. “Strategies for Biomolecular Analysis and Continuous Physiological Monitoring.” Journal of the American Chemical Society, 2021.


BibTeX   Click to copy

@article{a2021a,
  title = {Strategies for Biomolecular Analysis and Continuous Physiological Monitoring.},
  year = {2021},
  journal = {Journal of the American Chemical Society},
  author = {Clifford, A. and Das, Jagotamoy and Yousefi, Hanie and Mahmud, Alam and Chen, Jenise B. and Kelley, S.}
}

Abstract

Portable devices capable of rapid disease detection and health monitoring are crucial to decentralizing diagnostics from clinical laboratories to the patient point-of-need. Although technologies have been developed targeting this challenge, many require the use of reporter molecules or reagents that complicate the automation and autonomy of sensors. New work in the field has targeted reagentless approaches to enable breakthroughs that will allow personalized monitoring of a wide range of biomarkers on demand. This Perspective focuses on the ability of reagentless platforms to revolutionize the field of sensing by allowing rapid and real-time analysis in resource-poor settings. First, we will highlight advantages of reagentless sensing techniques, specifically electrochemical detection strategies. Advances in this field, including the development of wearable and in situ sensors capable of real-time monitoring of biomarkers such as nucleic acids, proteins, viral particles, bacteria, therapeutic agents, and metabolites, will be discussed. Reagentless platforms which allow for wash-free, calibration free-detection with increased dynamic range are highlighted as a key technological advance for autonomous sensing applications. Furthermore, we will highlight remaining challenges which must be overcome to enable widespread use of reagentless devices. Finally, future prospects and potential breakthroughs in precision medicine that will arise as a result of further development of reagentless sensing approaches are discussed.


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in